Age-Related Intraneuronal Aggregation of Amyloid-β in Endosomes, Mitochondria, Autophagosomes, and Lysosomes

Overview

Journal J Alzheimers Dis

Publisher Sage Publications

Specialties Geriatrics
Neurology

Date 2019 Nov 28

PMID 31771065

Citations 22

Authors

Gregory J Brewer

Robert A Herrera

Stephan Philipp

Justyna Sosna

Jorge Mauricio Reyes-Ruiz

Charles G Glabe

Affiliations

Soon will be listed here.

Abstract

This work provides new insight into the age-related basis of Alzheimer's disease (AD), the composition of intraneuronal amyloid (iAβ), and the mechanism of an age-related increase in iAβ in adult AD-model mouse neurons. A new end-specific antibody for Aβ45 and another for aggregated forms of Aβ provide new insight into the composition of iAβ and the mechanism of accumulation in old adult neurons from the 3xTg-AD model mouse. iAβ levels containing aggregates of Aβ45 increased 30-50-fold in neurons from young to old age and were further stimulated upon glutamate treatment. iAβ was 8 times more abundant in 3xTg-AD than non-transgenic neurons with imaged particle sizes following the same log-log distribution, suggesting a similar snow-ball mechanism of intracellular biogenesis. Pathologically misfolded and mislocalized Alz50 tau colocalized with iAβ and rapidly increased following a brief metabolic stress with glutamate. AβPP-CTF, Aβ45, and aggregated Aβ colocalized most strongly with mitochondria and endosomes and less with lysosomes and autophagosomes. Differences in iAβ by sex were minor. These results suggest that incomplete carboxyl-terminal trimming of long Aβs by gamma-secretase produced large intracellular deposits which limited completion of autophagy in aged neurons. Understanding the mechanism of age-related changes in iAβ processing may lead to application of countermeasures to prolong dementia-free health span.

Citing Articles

Production of Amyloid-β in the Aβ-Protein-Precursor Proteolytic Pathway Is Discontinued or Severely Suppressed in Alzheimer's Disease-Affected Neurons: Contesting the 'Obvious'.

Volloch V, Rits-Volloch S Genes (Basel). 2025; 16(1.

PMID: 39858593 PMC: 11764795. DOI: 10.3390/genes16010046.

Clearance of beta-amyloid and tau aggregates is size dependent and altered by an inflammatory challenge.

Fertan E, Hung C, Danial J, Lam J, Preman P, Albertini G Brain Commun. 2025; 7(1):fcae454.

PMID: 39749010 PMC: 11694676. DOI: 10.1093/braincomms/fcae454.

Mitochondrial dysfunction, cause or consequence in neurodegenerative diseases?.

Van Acker Z, Leroy T, Annaert W Bioessays. 2024; 47(1):e2400023.

PMID: 39367555 PMC: 11662158. DOI: 10.1002/bies.202400023.

Quintessential Synergy: Concurrent Transient Administration of Integrated Stress Response Inhibitors and BACE1 and/or BACE2 Activators as the Optimal Therapeutic Strategy for Alzheimer's Disease.

Volloch V, Rits-Volloch S Int J Mol Sci. 2024; 25(18).

PMID: 39337400 PMC: 11432332. DOI: 10.3390/ijms25189913.

ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.

Volloch V, Rits-Volloch S Int J Mol Sci. 2024; 25(11).

PMID: 38892224 PMC: 11172602. DOI: 10.3390/ijms25116036.

References

Ghosh D, LeVault K, Barnett A, Brewer G . A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons. J Neurosci. 2012; 32(17):5821-32. PMC: 3376759. DOI: 10.1523/JNEUROSCI.6192-11.2012. View

Colacurcio D, Pensalfini A, Jiang Y, Nixon R . Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease. Free Radic Biol Med. 2017; 114:40-51. PMC: 5748263. DOI: 10.1016/j.freeradbiomed.2017.10.001. View

Fernandez M, Klutkowski J, Freret T, Wolfe M . Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid β-peptides (Aβ) by γ-secretase to increase 42-to-40-residue Aβ. J Biol Chem. 2014; 289(45):31043-52. PMC: 4223309. DOI: 10.1074/jbc.M114.581165. View

Reddy P, Yin X, Manczak M, Kumar S, Pradeepkiran J, Vijayan M . Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease. Hum Mol Genet. 2018; 27(14):2502-2516. PMC: 6031001. DOI: 10.1093/hmg/ddy154. View

Costes S, Daelemans D, Cho E, Dobbin Z, Pavlakis G, Lockett S . Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J. 2004; 86(6):3993-4003. PMC: 1304300. DOI: 10.1529/biophysj.103.038422. View

Wong Y, Ysselstein D, Krainc D . Mitochondria-lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis. Nature. 2018; 554(7692):382-386. PMC: 6209448. DOI: 10.1038/nature25486. View

Oddo S, Caccamo A, Shepherd J, Murphy M, Golde T, Kayed R . Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003; 39(3):409-21. DOI: 10.1016/s0896-6273(03)00434-3. View

Hatami A, Albay 3rd R, Monjazeb S, Milton S, Glabe C . Monoclonal antibodies against Aβ42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain. J Biol Chem. 2014; 289(46):32131-32143. PMC: 4231689. DOI: 10.1074/jbc.M114.594846. View

Billings L, Oddo S, Green K, McGaugh J, LaFerla F . Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron. 2005; 45(5):675-88. DOI: 10.1016/j.neuron.2005.01.040. View

10.

Joshi G, Gan K, Johnson D, Johnson J . Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy. Neurobiol Aging. 2014; 36(2):664-79. PMC: 4315753. DOI: 10.1016/j.neurobiolaging.2014.09.004. View

11.

Kumar A, Yegla B, Foster T . Redox Signaling in Neurotransmission and Cognition During Aging. Antioxid Redox Signal. 2017; 28(18):1724-1745. PMC: 5962336. DOI: 10.1089/ars.2017.7111. View

12.

Pensalfini A, Albay 3rd R, Rasool S, Wu J, Hatami A, Arai H . Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques. Neurobiol Dis. 2014; 71:53-61. PMC: 4179983. DOI: 10.1016/j.nbd.2014.07.011. View

13.

Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima-Kawashima M, Funamoto S . gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci. 2009; 29(41):13042-52. PMC: 6665297. DOI: 10.1523/JNEUROSCI.2362-09.2009. View

14.

BURDICK D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A . Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem. 1992; 267(1):546-54. View

15.

Takahashi R, Nagao T, Gouras G . Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease. Pathol Int. 2017; 67(4):185-193. DOI: 10.1111/pin.12520. View

16.

Leon W, Canneva F, Partridge V, Allard S, Ferretti M, DeWilde A . A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. J Alzheimers Dis. 2010; 20(1):113-26. DOI: 10.3233/JAD-2010-1349. View

17.

Mousavi S, Kjeken R, Berg T, Seglen P, Berg T, Brech A . Effects of inhibitors of the vacuolar proton pump on hepatic heterophagy and autophagy. Biochim Biophys Acta. 2001; 1510(1-2):243-57. DOI: 10.1016/s0005-2736(00)00354-0. View

18.

Oddo S, Caccamo A, Smith I, Green K, LaFerla F . A dynamic relationship between intracellular and extracellular pools of Abeta. Am J Pathol. 2006; 168(1):184-94. PMC: 1592652. DOI: 10.2353/ajpath.2006.050593. View

19.

Doody R, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S . A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013; 369(4):341-50. DOI: 10.1056/NEJMoa1210951. View

20.

Ghosh D, LeVault K, Brewer G . Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons. Aging Cell. 2014; 13(4):631-40. PMC: 4116450. DOI: 10.1111/acel.12216. View